Detalhe da pesquisa
1.
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Pediatr Blood Cancer
; 71(1): e30735, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37859597
2.
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
Pediatr Blood Cancer
; 63(6): 1019-23, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864375
3.
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma.
JCO Precis Oncol
; 8: e2300297, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295320
4.
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.
Cell Rep
; 43(5): 114165, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691450
5.
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
Anticancer Drugs
; 24(5): 484-93, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23466651
6.
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma.
bioRxiv
; 2023 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163024
7.
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
bioRxiv
; 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693610
8.
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
bioRxiv
; 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425883
9.
Modulation of matrix remodeling by SPARC in neoplastic progression.
Semin Cell Dev Biol
; 21(1): 55-65, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19958839
10.
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.
Anticancer Drugs
; 23(10): 1054-66, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863973
11.
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
Pediatr Blood Cancer
; 59(4): 642-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22147414
12.
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.
Blood
; 114(20): 4592-600, 2009 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19710505
13.
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
Pediatr Blood Cancer
; 56(1): 164-7, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20860039
14.
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
Mol Cancer
; 9: 138, 2010 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525313
15.
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
BMC Cancer
; 10: 286, 2010 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546602
16.
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
Clin Cancer Res
; 26(6): 1309-1317, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852832
17.
Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
Mod Pathol
; 22(7): 950-8, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19407854
18.
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Cancer Res
; 67(4): 1716-24, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308113
19.
DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
Cancer Res
; 79(3): 650-662, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30538122
20.
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Mol Cancer Ther
; 18(3): 507-516, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674566